US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings Inc.

0.0433

0.0000

Volume:- -

Turnover:- -

Market Cap:8.52M

PE:-0.20

High:0.0433

Open:0.0433

Low:0.0433

Close:0.0433

52wk High:0.0800

52wk Low:0.0301

Shares:196.71M

Float Shares:196.71M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2138

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Tevogen Bio Holdings Inc - Approves Reverse Stock Split at 50 for 1 Ratio

THOMSON REUTERS

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

THOMSON REUTERS

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and Its Digital Care Management Platform Clinicus

THOMSON REUTERS

Tevogen Bio Holdings Inc - Deal Could Make Tevogen Revenue-Generating Healthcare Enterprise

THOMSON REUTERS

Tevogen Reports Major Clinical Milestone: Expands Hla Coverage of Its Investigational Precision T Cell Therapy for Acute and Long Covid

THOMSON REUTERS

Tevogen Bio Holdings Inc - Gaap Financials for Qtr Show $129 Mln Accumulated Deficit

THOMSON REUTERS

BRIEF-Tevogen Says Actively Preparing For Next Stage Of Development Of TVGN 489

Tevogen Cio and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks Data + AI World Tour in Boston

THOMSON REUTERS

Tevogen Bio Holdings Inc - Tvgn 116 Cumulative 5-Year Top-Line Revenue Forecast Is Estimated to Be About $6.5 Billion

THOMSON REUTERS

Tevogen Bio Holdings Inc - Values Tvgn-489 at $9-$11 Bln Risk-Adjusted Net Present Value

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVGNW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0433,"timestamp":1772571600000,"preClose":0.0433,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":196705066,"shares":196705066,"eps":-0.2138,"marketStatus":"Pre-Mkt","change":0,"latestTime":"03-04 08:37:50 EST","open":0.0433,"high":0.0433,"low":0.0433,"amount":0,"amplitude":0,"askPrice":0.0557,"askSize":100,"bidPrice":0.0269,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.2138,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772634600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0433,"postHourTrading":{"tag":"盘后","latestPrice":0.0433,"preClose":0.0433,"latestTime":"16:15 EST","volume":46,"amount":1.84,"timestamp":1772572552257,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":196705066,"roa":"--","roe":"--","lyrEps":0,"shares":196705066,"dividePrice":0,"high":0.0433,"amplitude":0,"preClose":0.0433,"low":0.0433,"week52Low":0.03011,"pbRate":"--","week52High":0.08,"institutionHeld":0,"latestPrice":0.0433,"eps":-0.2138,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.2138,"open":0.0433,"prevYearClose":0.0422,"prevWeekClose":0.0448,"prevMonthClose":0.0448,"prevQuarterClose":0.0422,"fiveDayClose":0.0434,"twentyDayClose":0.0428,"sixtyDayClose":0.0446},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGNW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616558318","title":"Tevogen Bio Holdings Inc - Approves Reverse Stock Split at 50 for 1 Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558318","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558318?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA5FG3QH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2614861617","title":"Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2614861617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614861617?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:20","pubTimestamp":1772220000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA6Z07NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2614402940","title":"Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and Its Digital Care Management Platform Clinicus","url":"https://stock-news.laohu8.com/highlight/detail?id=2614402940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614402940?lang=en_us&edition=fundamental","pubTime":"2026-02-26 22:20","pubTimestamp":1772115600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA5DM9F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2614028807","title":"Tevogen Bio Holdings Inc - Deal Could Make Tevogen Revenue-Generating Healthcare Enterprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2614028807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614028807?lang=en_us&edition=fundamental","pubTime":"2026-02-26 22:20","pubTimestamp":1772115600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA5DM9F4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2581706587","title":"Tevogen Reports Major Clinical Milestone: Expands Hla Coverage of Its Investigational Precision T Cell Therapy for Acute and Long Covid","url":"https://stock-news.laohu8.com/highlight/detail?id=2581706587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581706587?lang=en_us&edition=fundamental","pubTime":"2025-11-06 04:20","pubTimestamp":1762374000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA9RJPJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2580242570","title":"Tevogen Bio Holdings Inc - Gaap Financials for Qtr Show $129 Mln Accumulated Deficit","url":"https://stock-news.laohu8.com/highlight/detail?id=2580242570","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580242570?lang=en_us&edition=fundamental","pubTime":"2025-11-04 03:46","pubTimestamp":1762199161,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF249:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2575756840","title":"BRIEF-Tevogen Says Actively Preparing For Next Stage Of Development Of TVGN 489","url":"https://stock-news.laohu8.com/highlight/detail?id=2575756840","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575756840?lang=en_us&edition=fundamental","pubTime":"2025-10-16 03:56","pubTimestamp":1760558182,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Says Actively Preparing For Next Stage Of Development Of TVGN 489Oct 15 (Reuters) - Tevogen Bio Holdings Inc TVGN.O:TEVOGEN BIO HOLDINGS INC - TO COLLABORATE TO EXPEDITE DEVELOPMENT OF T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nFWN3VW2DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2566835629","title":"Tevogen Cio and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks Data + AI World Tour in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2566835629","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566835629?lang=en_us&edition=fundamental","pubTime":"2025-09-10 23:59","pubTimestamp":1757519942,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA3KBB6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2566610359","title":"Tevogen Bio Holdings Inc - Tvgn 116 Cumulative 5-Year Top-Line Revenue Forecast Is Estimated to Be About $6.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2566610359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566610359?lang=en_us&edition=fundamental","pubTime":"2025-09-10 03:17","pubTimestamp":1757445446,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2565768233","title":"Tevogen Bio Holdings Inc - Values Tvgn-489 at $9-$11 Bln Risk-Adjusted Net Present Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2565768233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565768233?lang=en_us&edition=fundamental","pubTime":"2025-09-08 21:28","pubTimestamp":1757338105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1E4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}